These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
542 related items for PubMed ID: 21482488
21. In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates. Tan TY, Ng LS, Tan E, Huang G. J Antimicrob Chemother; 2007 Aug; 60(2):421-3. PubMed ID: 17540671 [Abstract] [Full Text] [Related]
22. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii. Song JY, Kee SY, Hwang IS, Seo YB, Jeong HW, Kim WJ, Cheong HJ. J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672 [Abstract] [Full Text] [Related]
28. Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis. Dinc G, Demiraslan H, Elmali F, Ahmed SS, Metan G, Alp E, Doganay M. Chemotherapy; 2013 Aug; 59(5):325-9. PubMed ID: 24525528 [Abstract] [Full Text] [Related]
30. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO. Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562 [Abstract] [Full Text] [Related]
32. Systematic Review of Antimicrobial Resistance of Clinical Acinetobacter baumannii Isolates in Iran: An Update. Razavi Nikoo H, Ardebili A, Mardaneh J. Microb Drug Resist; 2017 Sep; 23(6):744-756. PubMed ID: 28085571 [Abstract] [Full Text] [Related]
35. Bloodstream infections caused by Acinetobacter species with reduced susceptibility to tigecycline: clinical features and risk factors. Park GE, Kang CI, Cha MK, Cho SY, Seok H, Lee JH, Kim JY, Ha YE, Chung DR, Peck KR, Lee NY, Song JH. Int J Infect Dis; 2017 Sep; 62():26-31. PubMed ID: 28676346 [Abstract] [Full Text] [Related]
36. In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group. Arroyo LA, Mateos I, González V, Aznar J. Antimicrob Agents Chemother; 2009 Mar; 53(3):1295-6. PubMed ID: 19075049 [No Abstract] [Full Text] [Related]
37. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period. Jasemi S, Douraghi M, Adibhesami H, Zeraati H, Rahbar M, Boroumand MA, Aliramezani A, Ghourchian S, Mohammadzadeh M. Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896 [Abstract] [Full Text] [Related]
38. Synergistic interactions between colistin and meropenem against extensively drug-resistant and pandrug-resistant Acinetobacter baumannii isolated from ICU patients. Vourli S, Frantzeskaki F, Meletiadis J, Stournara L, Armaganidis A, Zerva L, Dimopoulos G. Int J Antimicrob Agents; 2015 Jun; 45(6):670-1. PubMed ID: 25795317 [No Abstract] [Full Text] [Related]
39. In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia. Cikman A, Gulhan B, Aydin M, Ceylan MR, Parlak M, Karakecili F, Karagoz A. Int J Med Sci; 2015 Jun; 12(9):695-700. PubMed ID: 26392806 [Abstract] [Full Text] [Related]
40. Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model. Fan B, Guan J, Wang X, Cong Y. PLoS One; 2016 Jun; 11(6):e0157757. PubMed ID: 27315107 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]